Liabooks Home|PRISM News
PRISM

#Biosecure Act

Total 2 articles

The Pharma Paradox: Why Big Pharma's $171B Patent Cliff Leads Straight to China
EconomyEN
The Pharma Paradox: Why Big Pharma's $171B Patent Cliff Leads Straight to China

Big Pharma faces a $171B revenue cliff. Their solution? Chinese biotech. Our analysis unpacks the high-stakes clash between economic need and geopolitical risk.

The New Tech Iron Curtain: US Law Now Mandates a US-China Decoupling
PoliticsEN
The New Tech Iron Curtain: US Law Now Mandates a US-China Decoupling

The 2025 US defense bill codifies a tech and capital blockade against China. This analysis explores the impact on biotech, VC, and global supply chains.